Soluble Urokinase Receptor and Liver Disease

This publication has 23 references indexed in Scilit:

• Serum soluble urokinase plasminogen activator receptor in alcoholics: Relation to liver disease severity, fibrogenesis, and alcohol use
  Journal of Gastroenterology and Hepatology, 2014
• Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure
  Liver International, 2014
• Soluble Urokinase Plasminogen Activator Receptor is Associated With Progressive Liver Fibrosis in Hepatitis C Infection
  Journal of Clinical Gastroenterology, 2012
• Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis
  Liver International, 2011
• Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
  Nature Medicine, 2011
• suPAR: The Molecular Crystal Ball
  Disease Markers, 2009
• Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B
  Thrombosis Research, 2009
• Modification of kidney barrier function by the urokinase receptor
  Nature Medicine, 2007
• Acute renal dysfunction in liver diseases
  World Journal of Gastroenterology, 2007
• An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator
  FEBS Letters, 1993